Physician profile
Alejandro Rodriguez
NPI 1023182011
$10,070.97
in general payments reported to CMS, 2019-2025
56 companies · $1,397 in 2025
The $1,397 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $790 · 2020: $834 · 2021: $1,031 · 2022: $1,738 · 2023: $1,788 · 2024: $2,493 · 2025: $1,397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,639 · Education: $38.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,639.10 |
| Education | $38.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $891.90 | 2023-2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $815.28 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Coloplast Corp | $674.45 | 2019-2025 | Speedicath, Porges Coloplast |
| Edap Technomed INC | $636.00 | 2024 | |
| Astellas Pharma US INC | $569.86 | 2019-2024 | Myrbetriq, Veozah, Xtandi |
| Abbvie INC. | $531.16 | 2019-2025 | Botox, Lupron Depot |
| Bayer Healthcare Pharmaceuticals INC. | $503.42 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $480.86 | 2019-2023 | Aveed, Xiaflex, Edex |
| Janssen Biotech, INC. | $472.67 | 2019-2025 | Erleada, Akeega, Balversa |
| Urovant Sciences INC | $392.44 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $316.52 | 2022-2025 | Pylarify |
| Medtronic, INC. | $314.58 | 2021-2024 | Interstim |
| Urogen Pharma, INC. | $297.30 | 2022-2025 | Jelmyto |
| Tolmar, INC. | $248.47 | 2023-2025 | Eligard, Jatenzo |
| Merck Sharp & Dohme LLC | $225.80 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.